bf/NASDAQ:ADMP_icon.jpeg

NASDAQ:ADMP

Adamis Pharmaceuticals Corporation

  • Stock

USD

Last Close

0.77

07/09 19:59

Market Cap

7.25M

Beta: 1.23

Volume Today

119.48K

Avg: 1.54M

PE Ratio

−0.12

PFCF: −0.54

Mar '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
0.17
-
0.25
48.44%
0.26
1.65%
0.46
78.80%
0.54
15.83%
0.06
89.23%
0.44
654.46%
cash conversion cycle
-45.48
-
-30.67
32.56%
-5.27
82.82%
-21.04
299.25%
14.93
170.94%
797.87
5,245.55%
-311.89
139.09%
cash per share
51.49
-
21.52
58.21%
16.36
23.96%
42.77
161.43%
34.51
19.31%
11.58
66.45%
6.19
46.57%
11.28
82.26%
0.01
99.94%
company equity multiplier
1.24
-
1.30
4.38%
1.49
15.42%
1.30
13.04%
1.25
3.84%
1.33
6.21%
8.83
564.80%
1.48
83.23%
-13.53
1,014.20%
days of inventory outstanding
70.84
-
89.75
26.69%
122.15
36.10%
48.60
60.21%
76.36
57.12%
22.23
70.88%
73.08
228.67%
days of payables outstanding
161.73
-
143.60
11.21%
155.37
8.20%
100.63
35.23%
85.57
14.97%
199.39
133.01%
468.23
134.84%
days of sales outstanding
45.41
-
23.18
48.96%
27.95
20.59%
30.99
10.89%
24.14
22.12%
975.02
3,939.82%
83.27
91.46%
dividend yield
ebit per revenue
-3.89
-
-1.90
51.30%
-2.62
37.95%
-1.31
49.82%
-2.25
71.59%
-14.52
544.61%
-5.27
63.71%
ebt per ebit
1.86
-
0.98
47.19%
0.95
2.78%
1.04
9.58%
1.00
4.42%
1.01
1.15%
1.33
31.45%
1.08
18.68%
1.05
3.10%
effective tax rate
-1.06
-
0.19
-
0.01
93.12%
0.01
28.48%
-0.00
103.16%
-0.00
85.13%
-0.00
47.73%
-0.00
231.84%
enterprise value multiple
-10.18
-
-5.26
48.37%
-2.58
50.95%
-5.00
93.97%
-1.97
60.55%
-1.26
36.28%
-1.12
10.75%
-2.11
88.21%
-73.14
3,363.00%
fixed asset turnover
1.32
-
1.99
50.75%
1.53
23.29%
1.63
6.82%
1.48
9.08%
0.74
50.17%
2.96
300.14%
free cash flow per share
-159.89
-
-54.50
65.92%
-85.12
56.20%
-42.52
50.04%
-64.82
52.43%
-29.90
53.87%
-19.72
34.06%
-18.94
3.92%
-0.18
99.06%
gross profit margin
0.25
-
0.43
72.78%
0.35
18.93%
0.30
14.41%
0.10
67.06%
-2.11
2,236.19%
-0.30
85.75%
interest coverage
-0.51
-
-117.56
-
-107.18
8.83%
-250.14
133.39%
-235.51
5.85%
-233.22
0.97%
-4.82K
1,968.12%
-567.90
88.23%
inventory turnover
5.15
-
4.07
21.07%
2.99
26.52%
7.51
151.33%
4.78
36.35%
16.42
243.45%
4.99
69.57%
long term debt to capitalization
0.11
-
0.06
43.33%
0.04
-
0.36
820.64%
0.01
96.41%
net income per ebt
1
-
1
0%
0.81
19.05%
0.99
21.92%
0.99
0.38%
1.00
0.98%
1.00
0.03%
1.00
0.00%
1.00
0.01%
net profit margin
-3.00
-
-1.95
34.93%
-2.59
32.35%
-1.33
48.74%
-2.99
125.50%
-15.67
424.21%
-5.51
64.84%
operating cash flow per share
-64.61
-
-54.50
15.65%
-84.64
55.31%
-37.37
55.85%
-58.49
56.53%
-26.13
55.32%
-18.86
27.83%
-18.35
2.72%
-0.17
99.06%
operating cycle
116.25
-
112.93
2.86%
150.10
32.92%
79.59
46.97%
100.50
26.26%
997.25
892.32%
156.34
84.32%
operating profit margin
-3.89
-
-1.90
51.30%
-2.62
37.95%
-1.31
49.82%
-2.25
71.59%
-14.52
544.61%
-5.27
63.71%
payables turnover
2.26
-
2.54
12.63%
2.35
7.58%
3.63
54.39%
4.27
17.60%
1.83
57.08%
0.78
57.42%
pretax profit margin
-3.71
-
-1.98
46.63%
-2.61
31.85%
-1.32
49.24%
-2.99
125.55%
-15.67
424.22%
-5.51
64.84%
price fair value
3.83
-
7.70
100.78%
2.18
71.67%
3.15
44.64%
1.88
40.29%
1.04
45.03%
10.76
939.33%
3.37
68.68%
-2.20K
65,315.40%
receivables turnover
8.04
-
15.75
95.92%
13.06
17.07%
11.78
9.82%
15.12
28.41%
0.37
97.52%
4.38
1,070.94%
return on assets
-0.54
-
-1.13
108.62%
-0.51
54.28%
-0.50
3.41%
-0.67
34.53%
-0.61
8.35%
-1.60
161.20%
-0.90
43.54%
-2.40
165.30%
return on capital employed
-0.36
-
-1.49
312.33%
-0.86
41.91%
-0.58
32.67%
-0.84
44.95%
-0.77
8.51%
-3.40
341.06%
-1.18
65.19%
53.89
4,649.50%
return on equity
-0.67
-
-1.46
117.75%
-0.77
47.23%
-0.65
16.01%
-0.84
29.36%
-0.81
2.65%
-14.12
1,636.48%
-1.34
90.53%
32.42
2,525.35%
total debt to capitalization
0.03
-
0.23
-
0.11
49.83%
0.05
53.84%
0.10
93.95%
0.66
551.36%
0.03
96.07%
-0.74
2,924.31%

All numbers in USD (except ratios and percentages)